| 1. |
Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer, 1977, 39(6 Suppl): 2827-2839.
|
| 2. |
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 2002, 347(16): 1233-1241.
|
| 3. |
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med, 2002, 347(16): 1227-1232.
|
| 4. |
Fisher B, Wolmark N. New concepts in the management of primary breast cancer. Cancer, 1975, 36(2): 627-632.
|
| 5. |
van Maaren MC, de Munck L, de Bock GH, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol, 2016, 17(8): 1158-1170.
|
| 6. |
Chiu AS, Thomas P, Killelea BK, et al. Regional variation in breast cancer surgery: results from the National Cancer Database (NCDB). Am J Surg, 2017, 214(5): 907-913.
|
| 7. |
张保宁. 乳腺癌保乳手术临床应用现状与发展趋势. 中国实用外科杂志, 2008, 28(7): 523-524.
|
| 8. |
Huang NS, Liu MY, Chen JJ, et al. Surgical management of breast cancer in China: a 15-year single-center retrospective study of 18,502 patients. Medicine (Baltimore), 2016, 95(45): e4201.
|
| 9. |
Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med, 1985, 312(11): 665-673.
|
| 10. |
Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer, 1990, 26(6): 671-673.
|
| 11. |
Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stagesⅠ and Ⅱ invasive breast cancer. Int J Radiat Oncol Biol Phys, 2014, 88(3): 553-564.
|
| 12. |
Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol, 2009, 27(10): 1615-1620.
|
| 13. |
Chakravorty A, Shrestha AK, Sanmugalingam N, et al. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery. Eur J Surg Oncol, 2012, 38(5): 395-398.
|
| 14. |
Iwuchukwu OC, Harvey JR, Dordea M, et al. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery－a review. Surg Oncol, 2012, 21(2): 133-141.
|
| 15. |
Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol, 2008, 26(5): 778-785.
|
| 16. |
Buchholz TA, Lehman CD, Harris JR, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol, 2008, 26(5): 791-797.
|
| 17. |
Straver ME, Loo CE, Rutgers EJ, et al. MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy. Ann Surg, 2010, 251(4): 701-707.
|
| 18. |
Marinovich ML, Houssami N, Macaskill P, et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst, 2013, 105(5): 321-333.
|
| 19. |
Yerushalmi R, Tyldesley S, Woods R, et al. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol, 2012, 23(4): 876-881.
|
| 20. |
Houvenaeghel G, Tallet A, Jalaguier-Coudray A, et al. Is breast conservative surgery a reasonable option in multifocal or multicentric tumors? World J Clin Oncol, 2016, 7(2): 234-242.
|
| 21. |
Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol, 2013, 31(19): 2382-2387.
|
| 22. |
Kunkler IH, Williams LJ, Jack WJ, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME Ⅱ): a randomised controlled trial. Lancet Oncol, 2015, 16(3): 266-273.
|
| 23. |
Abd-Alla HM, Lotayef MM, Abou Bakr A, et al. Ipsilateral in-breast tumor relapse after breast conservation therapy: true recurrence versus new primary tumor. J Egypt Natl Canc Inst, 2006, 18(3): 183-190.
|
| 24. |
Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma－5-year results of a randomized trial. Int J Radiat Oncol Biol Phys, 2007, 69(3): 694-702.
|
| 25. |
Shah C, Vicini F, Shaitelman SF, et al. The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation. Brachytherapy, 2017, [Epub ahead of print].
|
| 26. |
START Trialists’ Group; Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol, 2008, 9(4): 331-341.
|
| 27. |
START Trialists’ Group; Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet, 2008, 371(9618): 1098-1107.
|
| 28. |
Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med, 2010, 362(6): 513-520.
|
| 29. |
Francis A, Fallowfield L, Rea D. The LORIS trial: addressing overtreatment of ductal carcinoma in situ. Clin Oncol (R Coll Radiol), 2015, 27(1): 6-8.
|
| 30. |
Sagara Y, Mallory MA, Wong S, et al. Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg, 2015, 150(8): 739-745.
|
| 31. |
Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg, 1999, 134(10): 1064-1068.
|
| 32. |
Fornage BD, Sneige N, Ross MI, et al. Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology, 2004, 231(1): 215-224.
|
| 33. |
Grotenhuis BA, Vrijland WW, Klem TM. Radiofrequency ablation for early-stage breast cancer: treatment outcomes and practical considerations. Eur J Surg Oncol, 2013, 39(12): 1317-1324.
|
| 34. |
Wang J, Xie X, Wang X, et al. Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis. Surg Oncol, 2013, 22(4): 247-255.
|
| 35. |
Gangi A, Chung A, Mirocha J, et al. Breast-conserving therapy for triple-negative breast cancer. JAMA Surg, 2014, 149(3): 252-258.
|
1/5
WeChat